UPDATE: Aegerion Pharmaceuticals Files Registration Statement for Proposed Offering of 4.25M Shares

Loading...
Loading...
Aegerion Pharmaceuticals, Inc.
AEGR
announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the underwritten public offering of 3,250,000 shares of its common stock by the Company and 1,000,000 shares of its common stock by certain pre-IPO stockholders of the Company. In addition, the Company and the selling stockholders have granted the underwriters the option to purchase up to 637,500 additional shares to cover over-allotments.
Posted In: NewsOfferings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...